🇺🇸 FDA
Pipeline program

Salbutamol Aldo-Unión 100 microgramos/dosis suspensión para inhalación en envase a presión, Inhalation powder with lactose monohydrate and magnesium stearate, BREO ELLIPTA, Fluticasone furoate and Vilanterol inhalation powder 100 mcg/25 mcg

SAN-1138

Phase 3 small_molecule active

Quick answer

Salbutamol Aldo-Unión 100 microgramos/dosis suspensión para inhalación en envase a presión, Inhalation powder with lactose monohydrate and magnesium stearate, BREO ELLIPTA, Fluticasone furoate and Vilanterol inhalation powder 100 mcg/25 mcg for Asthma is a Phase 3 program (small_molecule) at Sandoz Pharmaceuticals d.d. with 1 ClinicalTrials.gov record(s).

Program details

Company
Sandoz Pharmaceuticals d.d.
Indication
Asthma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials